Osteoporosis

Audience: Patients and providers
Status: Clinical guide · patient + provider
Last updated: 2026-03-27

1. Clinical overview

Osteoporosis is reduced bone strength with increased fragility-fracture risk, and management should focus on fracture prevention rather than bone density numbers alone.

2. Common causes and risk factors

• Aging, postmenopausal estrogen loss, low body weight, glucocorticoids, smoking, alcohol excess, and falls risk are major drivers.
• CKD, malabsorption, hyperparathyroidism, and prolonged immobility can complicate management.

3. Typical symptoms

• Osteoporosis is often silent until fragility fracture occurs; vertebral compression may present with height loss or back pain.

4. Diagnosis and evaluation

• Use DXA-based assessment plus clinical fracture risk factors.
• Review prior fragility fracture, fall history, calcium/vitamin D intake, renal function, and secondary causes.
• Distinguish long-term fracture prevention from acute fracture management needs.

5. Treatment (non-pharmacologic)

• Resistance and balance training, protein adequacy, calcium/vitamin D sufficiency, and fall-risk reduction are foundational.
• Home safety, vision, footwear, and sedating medication review often matter as much as supplements.

6. Treatment (pharmacologic)

• Bisphosphonates such as alendronate, risedronate, zoledronic acid, or ibandronate are common first-line therapies for many high-risk patients.
• Denosumab is an important antiresorptive option, and anabolic therapies such as teriparatide, abaloparatide, or romosozumab are used in very high-risk disease.
• Long-term planning should include reassessment of treatment duration, drug-holiday decisions where appropriate, and renal-function constraints.

7. Monitoring and follow-up

• Monitor adherence, interval fractures, adverse effects, calcium/vitamin D status, and repeat BMD timing by risk.
• Review dental issues and rare long-term therapy risks in the right context without overstating them.

8. Practical counseling points

• Explain that treatment benefit is fracture prevention, not symptom relief.
• Reinforce administration technique for oral bisphosphonates.
• Fall prevention counseling should be explicit and repeated.

9. Red flags and escalation

• Escalate for new fragility fracture, severe back pain with suspected compression fracture, or very high fracture risk needing specialist-directed therapy.
• Seek specialist input when secondary osteoporosis is suspected or therapy selection is complex.

10. Guideline references

• National Osteoporosis Foundation resources.
• Endocrine Society osteoporosis guidance.
• AACE/ACE osteoporosis management recommendations.

Note: Educational guide only; not a substitute for individualized medical care.